The glucagon receptor component is hypothesised to increase energy expenditure and promote fat breakdown (lipolysis), potentially offering additional weight loss benefits
Metformin is considered the go-to drug for glucose management in people with type 2 diabetes, but many patients take second-line drugstype 2 diabetes drugs that arent insulinlike GLP-1s to assist with treatment, according to a study by Northwestern Medicine
NK cell activity rises by 400% within 14 days, while lymphocyte proliferation gains a 60% boost [7]
How GLP-1 receptor activation changes your entire gut The effects extend beyond simple slowing
Moreover, several cardiovascular trials have demonstrated a reduced risk of adverse cardiovascular events among type 2 diabetes patients with CVD or high cardiovascular risk who were treated with GLP-1RAs [10]
LDN has two downsides: It requires a doctors prescription and must be purchased from a compounding pharmacy